ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cannabis-based Medicines Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14P2736
Home | Market Reports | Health| Nursing
Global Cannabis based Medicines Market Insights Forecast to 2028
BUY CHAPTERS

Global Cannabis-based Medicines Market Insights, Forecast to 2030

Code: QYRE-Auto-14P2736
Report
December 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GW Pharmaceuticals Plc
Insys Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals

Cannabis-based Medicines Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cannabis-based Medicines Market

Cannabis-based Medicines Market

Marijuana (medical cannabis) is used to treat nausea, pain, anxiety, MS, insomnia, epilepsy, and other conditions. Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine. In the medicines market, Epidiolex, the first cannabis-based medication approved by the US Food and Drug Administration.
Market Analysis and Insights: Global Cannabis-based Medicines Market
The global Cannabis-based Medicines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Cannabis-based Medicines market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Cannabis-based Medicines, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cannabis-based Medicines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cannabis-based Medicines revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Cannabis-based Medicines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Cannabis-based Medicines revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Cannabis-based Medicines Market Report

Report Metric Details
Report Name Cannabis-based Medicines Market
CAGR 5%
Segment by Type
  • CBD (Cannabidiol) Based
  • THC (Tetrahydrocannabinol) Based
  • Others
Segment by Application
  • Oral Solution
  • Tablets
  • Patches
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals, ECHO Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Cannabis-based Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cannabis-based Medicines companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cannabis-based Medicines revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Cannabis-based Medicines Market report?

Ans: The main players in the Cannabis-based Medicines Market are GW Pharmaceuticals plc, INSYS Therapeutics, Aequus Pharmaceuticals, Axim Biotechnologies, Revive Therapeutics, MGC Pharmaceuticals, ECHO Pharmaceuticals

What are the Application segmentation covered in the Cannabis-based Medicines Market report?

Ans: The Applications covered in the Cannabis-based Medicines Market report are Oral Solution, Tablets, Patches, Others

What are the Type segmentation covered in the Cannabis-based Medicines Market report?

Ans: The Types covered in the Cannabis-based Medicines Market report are CBD (Cannabidiol) Based, THC (Tetrahydrocannabinol) Based, Others

Recommended Reports

Cannabis Related Markets

Herbal and Alternative

Mental Health Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cannabis-based Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 CBD (Cannabidiol) Based
1.2.3 THC (Tetrahydrocannabinol) Based
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cannabis-based Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Oral Solution
1.3.3 Tablets
1.3.4 Patches
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cannabis-based Medicines Market Perspective (2019-2030)
2.2 Global Cannabis-based Medicines Growth Trends by Region
2.2.1 Cannabis-based Medicines Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cannabis-based Medicines Historic Market Size by Region (2019-2024)
2.2.3 Cannabis-based Medicines Forecasted Market Size by Region (2025-2030)
2.3 Cannabis-based Medicines Market Dynamics
2.3.1 Cannabis-based Medicines Industry Trends
2.3.2 Cannabis-based Medicines Market Drivers
2.3.3 Cannabis-based Medicines Market Challenges
2.3.4 Cannabis-based Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cannabis-based Medicines by Players
3.1.1 Global Cannabis-based Medicines Revenue by Players (2019-2024)
3.1.2 Global Cannabis-based Medicines Revenue Market Share by Players (2019-2024)
3.2 Global Cannabis-based Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cannabis-based Medicines, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Cannabis-based Medicines Market Concentration Ratio
3.4.1 Global Cannabis-based Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cannabis-based Medicines Revenue in 2023
3.5 Global Key Players of Cannabis-based Medicines Head office and Area Served
3.6 Global Key Players of Cannabis-based Medicines, Product and Application
3.7 Global Key Players of Cannabis-based Medicines, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cannabis-based Medicines Breakdown Data by Type
4.1 Global Cannabis-based Medicines Historic Market Size by Type (2019-2024)
4.2 Global Cannabis-based Medicines Forecasted Market Size by Type (2025-2030)
5 Cannabis-based Medicines Breakdown Data by Application
5.1 Global Cannabis-based Medicines Historic Market Size by Application (2019-2024)
5.2 Global Cannabis-based Medicines Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cannabis-based Medicines Market Size (2019-2030)
6.2 North America Cannabis-based Medicines Market Size by Type
6.2.1 North America Cannabis-based Medicines Market Size by Type (2019-2024)
6.2.2 North America Cannabis-based Medicines Market Size by Type (2025-2030)
6.2.3 North America Cannabis-based Medicines Market Share by Type (2019-2030)
6.3 North America Cannabis-based Medicines Market Size by Application
6.3.1 North America Cannabis-based Medicines Market Size by Application (2019-2024)
6.3.2 North America Cannabis-based Medicines Market Size by Application (2025-2030)
6.3.3 North America Cannabis-based Medicines Market Share by Application (2019-2030)
6.4 North America Cannabis-based Medicines Market Size by Country
6.4.1 North America Cannabis-based Medicines Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Cannabis-based Medicines Market Size by Country (2019-2024)
6.4.3 North America Cannabis-based Medicines Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cannabis-based Medicines Market Size (2019-2030)
7.2 Europe Cannabis-based Medicines Market Size by Type
7.2.1 Europe Cannabis-based Medicines Market Size by Type (2019-2024)
7.2.2 Europe Cannabis-based Medicines Market Size by Type (2025-2030)
7.2.3 Europe Cannabis-based Medicines Market Share by Type (2019-2030)
7.3 Europe Cannabis-based Medicines Market Size by Application
7.3.1 Europe Cannabis-based Medicines Market Size by Application (2019-2024)
7.3.2 Europe Cannabis-based Medicines Market Size by Application (2025-2030)
7.3.3 Europe Cannabis-based Medicines Market Share by Application (2019-2030)
7.4 Europe Cannabis-based Medicines Market Size by Country
7.4.1 Europe Cannabis-based Medicines Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Cannabis-based Medicines Market Size by Country (2019-2024)
7.4.3 Europe Cannabis-based Medicines Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cannabis-based Medicines Market Size (2019-2030)
8.2 China Cannabis-based Medicines Market Size by Type
8.2.1 China Cannabis-based Medicines Market Size by Type (2019-2024)
8.2.2 China Cannabis-based Medicines Market Size by Type (2025-2030)
8.2.3 China Cannabis-based Medicines Market Share by Type (2019-2030)
8.3 China Cannabis-based Medicines Market Size by Application
8.3.1 China Cannabis-based Medicines Market Size by Application (2019-2024)
8.3.2 China Cannabis-based Medicines Market Size by Application (2025-2030)
8.3.3 China Cannabis-based Medicines Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Cannabis-based Medicines Market Size (2019-2030)
9.2 Asia Cannabis-based Medicines Market Size by Type
9.2.1 Asia Cannabis-based Medicines Market Size by Type (2019-2024)
9.2.2 Asia Cannabis-based Medicines Market Size by Type (2025-2030)
9.2.3 Asia Cannabis-based Medicines Market Share by Type (2019-2030)
9.3 Asia Cannabis-based Medicines Market Size by Application
9.3.1 Asia Cannabis-based Medicines Market Size by Application (2019-2024)
9.3.2 Asia Cannabis-based Medicines Market Size by Application (2025-2030)
9.3.3 Asia Cannabis-based Medicines Market Share by Application (2019-2030)
9.4 Asia Cannabis-based Medicines Market Size by Region
9.4.1 Asia Cannabis-based Medicines Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Cannabis-based Medicines Market Size by Region (2019-2024)
9.4.3 Asia Cannabis-based Medicines Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Cannabis-based Medicines Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Cannabis-based Medicines Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GW Pharmaceuticals plc
11.1.1 GW Pharmaceuticals plc Company Details
11.1.2 GW Pharmaceuticals plc Business Overview
11.1.3 GW Pharmaceuticals plc Cannabis-based Medicines Introduction
11.1.4 GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2019-2024)
11.1.5 GW Pharmaceuticals plc Recent Developments
11.2 INSYS Therapeutics
11.2.1 INSYS Therapeutics Company Details
11.2.2 INSYS Therapeutics Business Overview
11.2.3 INSYS Therapeutics Cannabis-based Medicines Introduction
11.2.4 INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2019-2024)
11.2.5 INSYS Therapeutics Recent Developments
11.3 Aequus Pharmaceuticals
11.3.1 Aequus Pharmaceuticals Company Details
11.3.2 Aequus Pharmaceuticals Business Overview
11.3.3 Aequus Pharmaceuticals Cannabis-based Medicines Introduction
11.3.4 Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024)
11.3.5 Aequus Pharmaceuticals Recent Developments
11.4 Axim Biotechnologies
11.4.1 Axim Biotechnologies Company Details
11.4.2 Axim Biotechnologies Business Overview
11.4.3 Axim Biotechnologies Cannabis-based Medicines Introduction
11.4.4 Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2019-2024)
11.4.5 Axim Biotechnologies Recent Developments
11.5 Revive Therapeutics
11.5.1 Revive Therapeutics Company Details
11.5.2 Revive Therapeutics Business Overview
11.5.3 Revive Therapeutics Cannabis-based Medicines Introduction
11.5.4 Revive Therapeutics Revenue in Cannabis-based Medicines Business (2019-2024)
11.5.5 Revive Therapeutics Recent Developments
11.6 MGC Pharmaceuticals
11.6.1 MGC Pharmaceuticals Company Details
11.6.2 MGC Pharmaceuticals Business Overview
11.6.3 MGC Pharmaceuticals Cannabis-based Medicines Introduction
11.6.4 MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024)
11.6.5 MGC Pharmaceuticals Recent Developments
11.7 ECHO Pharmaceuticals
11.7.1 ECHO Pharmaceuticals Company Details
11.7.2 ECHO Pharmaceuticals Business Overview
11.7.3 ECHO Pharmaceuticals Cannabis-based Medicines Introduction
11.7.4 ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024)
11.7.5 ECHO Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
GW Pharmaceuticals Plc
Insys Therapeutics
Aequus Pharmaceuticals
Axim Biotechnologies
Revive Therapeutics
MGC Pharmaceuticals
ECHO Pharmaceuticals
List of Tables
    Table 1. Global Cannabis-based Medicines Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of CBD (Cannabidiol) Based
    Table 3. Key Players of THC (Tetrahydrocannabinol) Based
    Table 4. Key Players of Others
    Table 5. Global Cannabis-based Medicines Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Cannabis-based Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Cannabis-based Medicines Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Cannabis-based Medicines Market Share by Region (2019-2024)
    Table 9. Global Cannabis-based Medicines Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Cannabis-based Medicines Market Share by Region (2025-2030)
    Table 11. Cannabis-based Medicines Market Trends
    Table 12. Cannabis-based Medicines Market Drivers
    Table 13. Cannabis-based Medicines Market Challenges
    Table 14. Cannabis-based Medicines Market Restraints
    Table 15. Global Cannabis-based Medicines Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Cannabis-based Medicines Revenue Share by Players (2019-2024)
    Table 17. Global Top Cannabis-based Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis-based Medicines as of 2023)
    Table 18. Global Cannabis-based Medicines Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Cannabis-based Medicines Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Cannabis-based Medicines, Headquarters and Area Served
    Table 21. Global Key Players of Cannabis-based Medicines, Product and Application
    Table 22. Global Key Players of Cannabis-based Medicines, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cannabis-based Medicines Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Cannabis-based Medicines Revenue Market Share by Type (2019-2024)
    Table 26. Global Cannabis-based Medicines Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Cannabis-based Medicines Revenue Market Share by Type (2025-2030)
    Table 28. Global Cannabis-based Medicines Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Cannabis-based Medicines Revenue Share by Application (2019-2024)
    Table 30. Global Cannabis-based Medicines Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Cannabis-based Medicines Revenue Share by Application (2025-2030)
    Table 32. North America Cannabis-based Medicines Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Cannabis-based Medicines Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Cannabis-based Medicines Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Cannabis-based Medicines Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Cannabis-based Medicines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Cannabis-based Medicines Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Cannabis-based Medicines Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Cannabis-based Medicines Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Cannabis-based Medicines Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Cannabis-based Medicines Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Cannabis-based Medicines Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Cannabis-based Medicines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Cannabis-based Medicines Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Cannabis-based Medicines Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Cannabis-based Medicines Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Cannabis-based Medicines Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Cannabis-based Medicines Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Cannabis-based Medicines Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Cannabis-based Medicines Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Cannabis-based Medicines Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Cannabis-based Medicines Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Cannabis-based Medicines Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Cannabis-based Medicines Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Cannabis-based Medicines Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Cannabis-based Medicines Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Cannabis-based Medicines Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size by Country (2025-2030) & (US$ Million)
    Table 64. GW Pharmaceuticals plc Company Details
    Table 65. GW Pharmaceuticals plc Business Overview
    Table 66. GW Pharmaceuticals plc Cannabis-based Medicines Product
    Table 67. GW Pharmaceuticals plc Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 68. GW Pharmaceuticals plc Recent Developments
    Table 69. INSYS Therapeutics Company Details
    Table 70. INSYS Therapeutics Business Overview
    Table 71. INSYS Therapeutics Cannabis-based Medicines Product
    Table 72. INSYS Therapeutics Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 73. INSYS Therapeutics Recent Developments
    Table 74. Aequus Pharmaceuticals Company Details
    Table 75. Aequus Pharmaceuticals Business Overview
    Table 76. Aequus Pharmaceuticals Cannabis-based Medicines Product
    Table 77. Aequus Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 78. Aequus Pharmaceuticals Recent Developments
    Table 79. Axim Biotechnologies Company Details
    Table 80. Axim Biotechnologies Business Overview
    Table 81. Axim Biotechnologies Cannabis-based Medicines Product
    Table 82. Axim Biotechnologies Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 83. Axim Biotechnologies Recent Developments
    Table 84. Revive Therapeutics Company Details
    Table 85. Revive Therapeutics Business Overview
    Table 86. Revive Therapeutics Cannabis-based Medicines Product
    Table 87. Revive Therapeutics Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 88. Revive Therapeutics Recent Developments
    Table 89. MGC Pharmaceuticals Company Details
    Table 90. MGC Pharmaceuticals Business Overview
    Table 91. MGC Pharmaceuticals Cannabis-based Medicines Product
    Table 92. MGC Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 93. MGC Pharmaceuticals Recent Developments
    Table 94. ECHO Pharmaceuticals Company Details
    Table 95. ECHO Pharmaceuticals Business Overview
    Table 96. ECHO Pharmaceuticals Cannabis-based Medicines Product
    Table 97. ECHO Pharmaceuticals Revenue in Cannabis-based Medicines Business (2019-2024) & (US$ Million)
    Table 98. ECHO Pharmaceuticals Recent Developments
    Table 99. Research Programs/Design for This Report
    Table 100. Key Data Information from Secondary Sources
    Table 101. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cannabis-based Medicines Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Cannabis-based Medicines Market Share by Type: 2023 VS 2030
    Figure 3. CBD (Cannabidiol) Based Features
    Figure 4. THC (Tetrahydrocannabinol) Based Features
    Figure 5. Others Features
    Figure 6. Global Cannabis-based Medicines Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Cannabis-based Medicines Market Share by Application: 2023 VS 2030
    Figure 8. Oral Solution Case Studies
    Figure 9. Tablets Case Studies
    Figure 10. Patches Case Studies
    Figure 11. Others Case Studies
    Figure 12. Cannabis-based Medicines Report Years Considered
    Figure 13. Global Cannabis-based Medicines Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Cannabis-based Medicines Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Cannabis-based Medicines Market Share by Region: 2023 VS 2030
    Figure 16. Global Cannabis-based Medicines Market Share by Players in 2023
    Figure 17. Global Top Cannabis-based Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cannabis-based Medicines as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Cannabis-based Medicines Revenue in 2023
    Figure 19. North America Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Cannabis-based Medicines Market Share by Type (2019-2030)
    Figure 21. North America Cannabis-based Medicines Market Share by Application (2019-2030)
    Figure 22. North America Cannabis-based Medicines Market Share by Country (2019-2030)
    Figure 23. United States Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Cannabis-based Medicines Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Cannabis-based Medicines Market Share by Type (2019-2030)
    Figure 27. Europe Cannabis-based Medicines Market Share by Application (2019-2030)
    Figure 28. Europe Cannabis-based Medicines Market Share by Country (2019-2030)
    Figure 29. Germany Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Cannabis-based Medicines Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Cannabis-based Medicines Market Share by Type (2019-2030)
    Figure 37. China Cannabis-based Medicines Market Share by Application (2019-2030)
    Figure 38. Asia Cannabis-based Medicines Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Cannabis-based Medicines Market Share by Type (2019-2030)
    Figure 40. Asia Cannabis-based Medicines Market Share by Application (2019-2030)
    Figure 41. Asia Cannabis-based Medicines Market Share by Region (2019-2030)
    Figure 42. Japan Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Cannabis-based Medicines Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Cannabis-based Medicines Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Cannabis-based Medicines Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Cannabis-based Medicines Market Share by Country (2019-2030)
    Figure 52. Brazil Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Cannabis-based Medicines Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GW Pharmaceuticals plc Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 59. INSYS Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 60. Aequus Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 61. Axim Biotechnologies Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 62. Revive Therapeutics Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 63. MGC Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 64. ECHO Pharmaceuticals Revenue Growth Rate in Cannabis-based Medicines Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Medical Cannabis Products Market Research Report 2025
Global Cannabis Pharmaceuticals Market Research Report 2024
Medical and Recreational Cannabis Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Legalized Cannabis Market Insights Forecast to 2030
Legal Cannabis for Medical Use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cannabis Drug Market Research Report 2024
Global Medicinal Grade Cannabis Market Research Report 2025
Global Medicinal Cannabis Market Research Report 2024
Global Controlled Release Cannabis Pills Market Research Report 2024
Global Cannabis Products Market Research Report 2024
Cannabis Use Disorder Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cannabis Oil Market Insights Forecast to 2030
Pharmaceutical Cannabis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cannabis Beverages Market Insights Forecast to 2030
Global Medical Marijuana Packaging Market Insights Forecast to 2030
Global Tetrahydrocannabinol THC and Cannabidiol CBD Market Research Report 2024
Pharmaceutical Marijuana MMJ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cannabinoid Derived Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plant based Cannabidiol CBD Nutraceuticals Market Insights Forecast to 2030
Cannabinoid based Antitumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions